35
Participants
Start Date
August 28, 2021
Primary Completion Date
November 30, 2021
Study Completion Date
December 30, 2021
Bacillus subtilis
Bacillus subtilis, a harmless intestinal commensal, has earned in recent years, great reputation as a vaccine production host and delivery vector with advantages such as low cost, safe for human consumption and straightforward administration. The technology team has succeeded engineering Bacillus subtilis with spore coat proteins resembling the proteins of the nucleus and spikes of coronal virus. This product could have a vaccine like activity within the intestinal environment.
DreamTec Research Limited, Hong Kong
Middle East Cell and Gene Therapy, Tehran
Middle East Cell and Gene Therapy
UNKNOWN
National Institute of Genetic Engineering and Biotechnology
UNKNOWN
DreamTec Research Limited
INDUSTRY